Regenovue Aqua Shine Plus

Regenovue

Aesthetic Injectable / Skin-Booster

Hyaluronic acid based mesotherapy / dermal booster

CE Marked as an injectable HA Based dermal filler / skin booster in applicable markets (subject to local regulations).
Manufactured under standards applicable to medical injectables and aesthetic products by NeoGenesis Co., Ltd., South Korea.

CE Marked as an injectable HA Based dermal filler / skin booster in applicable markets (subject to local regulations).
Manufactured under standards applicable to medical injectables and aesthetic products by NeoGenesis Co., Ltd., South Korea.

Hyaluronic acid based mesotherapy / dermal booster

Description

Regenovue Aqua Shine Plus is a hyaluronic acid–based biorevitalization injectable designed for facial and neck skin rejuvenation. The product uses minimally cross-linked HA (≈ 15 mg/ml) in a sterile phosphate-buffered saline (PBS, pH 7.0), supplied in 3 ml syringes (typically 3 syringes per pack). When injected into the superficial to mid-dermis, it delivers deep hydration, improves skin elasticity, smooths fine lines and wrinkles, tightens pores, and revitalizes skin tone and texture. A single session procedure of 10–20 minutes can yield visible improvements within 1–2 weeks, with effects lasting up to 6–8 months depending on patient factors.

Bnefits

Deep hydration for dry, dull or dehydrated skin through HA-based mesotherapy.
Improvement of skin elasticity and firmness by stimulating endogenous collagen and elastin production.
Reduction of fine lines, wrinkles and improvement of skin texture / smoothness.
Brightening and evening of skin tone, reduction of pigmentation, spots and skin dullness.
Pore tightening and improved skin clarity.
Non-volumizing rejuvenation (skin booster rather than filler), leading to natural-looking results.
Relatively quick procedure (10–20 min per session) with minimal downtime.
Effects potentially lasting up to 6–8 months with proper maintenance.

Indications

Skin dehydration and dryness, needing deep dermal hydration.
Loss of skin elasticity, early signs of aging, fine lines and wrinkles on face, neck, decolletage.
Dull, uneven skin tone, pigmentation, dark spots, and loss of radiance.
Large pores and rough skin texture requiring smoothing.
Need for non-volumizing skin boosting (e.g. patients who want hydration and glow without significant volume augmentation).

Composition

Minimally cross-linked hyaluronic acid (≈ 15 mg/ml) in buffered phosphate-saline (pH 7.0) solution.
Sterile saline-based gel; no bovine or animal-derived components.
Preservatives/backing buffer (as per manufacturer’s sterile injectable formulation) for stability and sterilization compatibility.

Formulation

Injectable mesotherapy/skin-booster gel intended for intradermal or superficial dermal injection.
Delivered in pre-filled sterile 3 ml syringes (often in a set of 3 syringes per pack).
Designed for professional use by trained aesthetic practitioners under sterile conditions.

Packaging

Pack containing 3 syringes × 3 ml each (total 9 ml), according to many distributors.
Sterile, individually capped syringes with sealed protective packaging to maintain sterility until use.
Labelled with product name, batch number, volume, storage instructions and manufacturer/importer information as required for injectable devices.

Usage

Intended for intradermal or superficial–mid dermal injection by a certified medical/aesthetic professional.
Cleanse and disinfect the treatment area prior to injection; local anesthetic may be applied per clinic protocol if needed.
Use fine gauge needles (e.g. 30–31G) or mesotherapy pens/micro-needling devices as appropriate; injection depth typically 0.8–1.5 mm (or per practitioner’s discretion).
Evenly distribute small aliquots across treatment area (face, neck, décolletage) to cover entire region.
Post-treatment: advise hydration, avoid makeup and avoid UV exposure for at least 24 hours; use sunscreen subsequently.
Recommend repeating treatment every 6–8 months (or as per practitioner’s protocol) to maintain results, or initial 2–3 sessions spaced 6–8 weeks apart for optimal effect.

Contraindications

Allergy or hypersensitivity to hyaluronic acid, buffer components or any excipient in the formulation.
Active skin infection, inflammation, ulceration or open wounds at the intended injection site.
Pregnancy and breastfeeding (many sources recommend avoiding elective aesthetic injectables during these periods).
Autoimmune or connective tissue disorders, or previous adverse reaction to dermal fillers/skin boosters — use only under specialist evaluation.
Use in unlicensed/untrained hands or without aseptic technique is contraindicated.

Adverse Effects

Temporary redness, swelling, bruising, or mild discomfort at injection sites.
Possible risk of allergic reaction, hypersensitivity or local inflammation, although the product is synthetic and biocompatible.
Transient uneven skin texture or lumps if injection is not evenly distributed or massage/integration is inadequate.
Risk of infection if aseptic technique is not strictly followed during injection or aftercare.

Storage Conditions

Store sealed syringes at room temperature, away from direct sunlight and heat (e.g. recommended 2–25 °C).
Keep in original packaging until use to maintain sterility and stability.
Protect from freezing or high temperatures; do not expose to excessive heat.

Duration

Effects often persist for approximately 6\u20138 months after a session, depending on individual skin factors and maintenance.

Onset

Initial hydration, smoothness and glow often visible within 1\u20132 weeks after injection; improvements in skin texture, elasticity and fine lines typically emerge gradually over 2\u20134 weeks.